Dyne Therapeutics, Inc. DYN Gain (Loss) on Disposition of Assets
Gain (Loss) on Disposition of Assets at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s gain (loss) on disposition of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s gain (loss) on disposition of assets?
- Dyne Therapeutics, Inc. (DYN) reported gain (loss) on disposition of assets of -$30K in Q1 2026.
- How has Dyne Therapeutics, Inc.'s gain (loss) on disposition of assets changed year-over-year?
- Dyne Therapeutics, Inc.'s gain (loss) on disposition of assets increased by 68.4% year-over-year, from -$95K to -$30K.